Preoperative Comorbidities Associated With Weight Loss Following Metabolic and Bariatric Surgery: A Rapid Review
Obesity Reviews · 2026
DOI: 10.1111/obr.70084 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Obesity Reviews, 2026. Verfasst von Evan Atlantis und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Western Sydney University, Campbelltown, New South Wales, Australia. Hauptthemen laut MEDLINE: Weight Loss, Bariatric Surgery, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Aim
This rapid review aims to summarize the evidence of weight loss following Metabolic and Bariatric Surgery (MBS) associated with preoperative comorbidities.
Methods
Electronic databases Medline and EMBASE were searched for relevant articles up to and including September 2023. Studies that reported associations between the presence of comorbidities and weight loss outcomes in adult patients (age ≥ 18 years) after MBS (with ≥ 6 months of follow‐up). Standardized mean differences (SMDs) with 95% confidence intervals (95% CIs) were calculated and pooled using random effects meta‐analysis. Heterogeneity was quantified using the I 2 statistic and tested for statistical significance using the Q‐statistic.
Results
Twenty‐three studies published between 2001 and 2023 were reviewed. Mental illness (SMD = −0.33, 95% CI: −0.53, −0.13; I 2 = 64.72%, Q statistic p = 0.01), type 2 diabetes mellitus (SMD = −0.20, 95% CI: −0.36, −0.03; I 2 = 56.88%, Q statistic p = 0.04), and sleep apnea (SMD = −0.28, 95% CI: −0.45, −0.12; I 2 = 27.39%, Q statistic p = 0.24) achieved slightly lower weight loss outcomes compared to those without these comorbidities. There was no significant difference in weight loss after bariatric surgery between individuals with and without preoperative hypertension (SMD = −0.10, 95% CI: −0.22, 0.03), dyslipidemia (SMD = −0.05, 95% CI: −0.20, 0.10), and metabolic syndrome (SMD = −0.19, 95% CI: −0.58, 0.19). While other comorbidities were also linked to reduced weight loss, the statistical significance of these findings was more variable.
Conclusions
Our evidence synthesis reveals an association between the presence of several preoperative comorbidities and less favorable weight loss outcomes following MBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Health Sciences, Western Sydney University, Campbelltown, New South Wales, Australia.
- Translational Health Research Institute, Western Sydney University, Campbelltown, New South Wales, Australia.
- School of Medicin, Western Sydney University, Campbelltown, New South Wales, Australia.
- Diabetes Obesity Metabolism Translational Research Unit, Western Sydney University, Campbelltown, New South Wales, Australia.
- South Western Sydney Metabolic Rehabilitation and Bariatric Program, Camden and Campbelltown Hospitals, Campbelltown, New South Wales, Australia.
ORCID-Profile: Milan Piya
Zitieren
APA
Atlantis, E., Mariadasan, G., Brooks, C., Piya, M., & Fahey, P. (2026). Preoperative Comorbidities Associated With Weight Loss Following Metabolic and Bariatric Surgery: A Rapid Review. Obesity Reviews. https://doi.org/10.1111/obr.70084
Vancouver
Atlantis E, Mariadasan G, Brooks C, Piya M, Fahey P. Preoperative Comorbidities Associated With Weight Loss Following Metabolic and Bariatric Surgery: A Rapid Review. Obesity Reviews. 2026. doi:10.1111/obr.70084
BibTeX
@article{Atlantis2026,
author = {Atlantis, Evan and Mariadasan, Gabriel and Brooks, Cristy and Piya, Milan and Fahey, Paul},
title = {Preoperative Comorbidities Associated With Weight Loss Following Metabolic and Bariatric Surgery: A Rapid Review},
journal = {Obesity Reviews},
year = {2026},
doi = {10.1111/obr.70084}
}
EUVIMED